Yahoo Web Search

Search results

  1. Aug 23, 2023 · David Schiff, MD, is a professor and co-director of UVA Cancer Center’s Neuro-Oncology Center. He has authored an editorial on a new drug for brain tumors with IDH gene mutation.

  2. Aug 25, 2023 · David Schiff, MD, the co-director of UVA Cancer Center’s Neuro-Oncology Center, has authored an editorial in the prestigious New England Journal of Medicine describing the potential...

  3. Dr. Schiff is a board certified physical medicine and rehabilitation specialist with expertise in spine care and pain management. He offers non-operative treatments such as injections, nerve testing, and exercise programs for neck and back pain.

  4. Schiff, David Primary Appointment. Professor, Neurology. Education. AB, General Studies, Harvard University, Cambridge, MA; MD, Medicine, Harvard Medicine School, Boston, MA; Intern, Internal Medicine, Brigham & Women’s Hospital, Harvard Medical School; Resident, Neurology, Harvard Longwood Neurology, Boston, MA

  5. Aug 23, 2023 · David Schiff, MD, co-director of UVA Cancer Center’s Neuro-Oncology Center, writes an editorial in the New England Journal of Medicine praising vorasidenib, a new drug for grade 2 IDH-mutant gliomas. The drug, which slows tumor growth and extends survival, could be the first targeted therapy for this type of brain tumor.

  6. Feb 16, 2022 · Our David Schiff, MD, has helped lead the development of important new guidelines that will improve care for brain metastases -- cancers that spread to the brain.

  7. People also ask

  8. Sep 29, 2023 · David Schiff, MD, the co-director of UVA Cancer Center’s Neuro-Oncology Center, has authored an editorial in the prestigious New England Journal of Medicine describing the potential...

  1. People also search for